A biomimetic liver cancer on-a-chip reveals a critical role of LIPOCALIN-2 in promoting hepatocellular carcinoma progression
Hepatic stellate cells (HSCs) represent a significant component of hepatocellular carcinoma (HCC) microenvironments which play a critical role in tumor progression and drug resistance. Tumor-on-a-chip technology has provided a powerful in vitro platform to investigate the crosstalk between activated...
Main Authors: | Peiliang Shen, Yuanyuan Jia, Weijia Zhou, Weiwei Zheng, Yueyao Wu, Suchen Qu, Shiyu Du, Siliang Wang, Huilian Shi, Jia Sun, Xin Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-11-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383523001454 |
Similar Items
-
Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review
by: Faezeh Hosseinzadeh, et al.
Published: (2018-09-01) -
Combined neurokinin-1 receptor antagonist and sorafenib is a promising approach for hepatocellular carcinoma therapy
by: Heba E. Sedky, et al.
Published: (2024-07-01) -
HepG2 exosomes coated luteolin nanoparticles remodeling hepatic stellate cells and combination with sorafenib for the treatment of hepatocellular carcinoma
by: Shengjie Ye, et al.
Published: (2024-02-01) -
Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
by: Koen G. A. M. Hussaarts, et al.
Published: (2021-01-01) -
Deciphering the role of KLRB1: a novel prognostic indicator in hepatocellular carcinoma
by: Siting Fang, et al.
Published: (2024-06-01)